The exploitation of a novel image-based risk stratification tool in early prostate cancer - the Re-IMAGINE Consortium

Project: Research

Project Details

StatusFinished
Effective start/end date1/06/201831/05/2023

Collaborative partners

  • King's College London
  • UCL University College London (Collaborating partner) (lead)
  • Imperial College London (Collaborating partner)
  • Institute of Cancer Research
  • Affidea BV
  • Chronix Biomedical Inc
  • GenomeDX Biosciences Inc
  • Image Analysis Ltd
  • Maxwell MRI
  • MDx Health SA
  • MIM Software Inc
  • Minomic International Ltd
  • ProteoMediX AG
  • Philips Research Eindhoven

Funding

  • MRC Medical Research Council: £5,179,120.00